Emergent BioSolutions to Participate in Series of Investor Conferences

GAITHERSBURG, Md., May 20, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that a member of the company’s senior management team will participate in the following investor conferences during the second quarter of 2019:

RBC Capital Markets – 2019 Global Healthcare ConferenceNew York, NYMay 21-22, 2019

Goldman Sachs – 40th Annual Global Healthcare Conference (1x1 Meetings Only)Rancho Palos Verdes, CAJune 11-13, 2019

Three Part Advisors – East Coast IDEAS ConferenceBoston, MAJune 12-13, 2019

BMO – Prescriptions for Success Healthcare Conference 2019New York, NYJune 25, 2019

Presentation dates and times will be updated on the Emergent website www.emergentbiosolutions.com under “Investors” as the information becomes available.

For these conferences, the company will be webcasting its presentation, which may include a discussion of the company's recent business developments as well as its most recently reported financial results and guidance. The webcasts will be available both live and by replay, accessible from the Emergent website.

About Emergent BioSolutionsEmergent BioSolutions Inc. is a global life sciences company seeking to protect and enhance life by focusing on providing specialty products for civilian and military populations that address accidental, deliberate, and naturally occurring public health threats. We aspire to be a Fortune 500 company recognized for protecting and enhancing life, driving innovation, and living our values. Additional information about the company may be found at www.emergentbiosolutions.com. Find us on LinkedIn and follow us on Twitter @emergentbiosolu and Instagram @life_at_emergent.

Investor Contact:Robert G. BurrowsVice President, Investor Relations240-631-3280[email protected]

Media Contact:Lynn KiefferVice President, Corporate Communications240-631-3391[email protected]

Source: Emergent BioSolutions

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• IBM misses Q2 targets as mainframe and software sales disappoint
• ADI Global sets revenue and earnings targets ahead of Resideo spin-off
• Wells Fargo climbs premarket after strong Q2 earnings beat